Asked by: Maya Ellis (Labour - Ribble Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that UKMDR audit fees remain affordable for UK based businesses who source medical devices from overseas manufacturers.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
In Great Britain, medical devices are regulated under the Medical Device Regulations 2002 (MDR 2002), which is available at the following link:
https://www.legislation.gov.uk/uksi/2002/618/contents/made
Manufacturers of the lowest risk medical devices can self-declare the conformity of their devices against these regulations, and manufacturers of medium and high-risk medical devices must seek third party conformity assessment from an approved body to obtain a UK Conformity Assessed (UKCA) marking.
Fees are set by the approved body themselves and vary depending on the specific service provided.
To protect supply, the government continues to accept CE-marked medical devices on the Great Britain market until 30 June 2028 or 2030, depending on the type of device and the legislation it complies with. If a device has a valid CE marking, the manufacturer is therefore not required to also obtain a UKCA marking. We will consult further on our long-term approach to the recognition of CE-marked medical devices later this year.
The Medicines and Healthcare products Regulatory Agency (MHRA) is currently developing a reformed regulatory framework for medical devices, designed to protect patient safety, while improving access to innovative medical devices. This will introduce an international reliance framework, allowing the MHRA to use the expertise and decision-making of other regulatory partners to introduce a new, streamlined, route to market for certain devices with prior approval from comparable regulatory countries (Australia, Canada and the US). This will reduce unwarranted regulatory burden on manufacturers of medical devices with overseas approval.
Asked by: Maya Ellis (Labour - Ribble Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help reduce waiting lists for diagnostic services at Preston Royal Hospital Lancashire Teaching Hospitals NHS Foundation Trust.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Lancashire Teaching Hospitals NHS Foundation Trust (the Trust) has agreed a Diagnostic Improvement Programme with key focuses including:
The Trust also makes use of mutual aid. In the NHS, mutual aid is the voluntary cooperation and resource-sharing between different healthcare organisations or sectors to meet shared needs, especially during emergencies or when systems are under extreme pressure. The Trust continues to scope other options to increase capacity and support from other local organisations via mutual aid.
Performance at the Trust has significantly improved against the Diagnostics Waiting Times and Activity data collection (DM01) six-week target from 49.3 percent of patients on the waiting list waiting in excess of 6 weeks from referral in June 2024, to 39.6 percent in June 2025.
Nationally, the government is supporting the NHS to recover diagnostic services and bring down waiting times through investment in new capacity and technology. At the Spending Review in June 2025, the Chancellor of the Exchequer announced £6 billion in capital funding across 5 years for new diagnostic, elective and urgent and emergency capacity in the NHS. This includes £600 million in 2025/26.
Asked by: Maya Ellis (Labour - Ribble Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to review the medical conditions on the list of exemptions for prescription charges.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
There are no plans to review the list of medical conditions that entitle someone to apply for a medical exemption certificate.
There are extensive arrangements in place in England to ensure that prescriptions are affordable for everyone. Approximately 89% of prescription items are dispensed free of charge in the community in England, and there is a wide range of exemptions from prescription charges already in place for which those with chronic illnesses may be eligible. Eligibility depends on the patient’s age, whether they are in qualifying full-time education, whether they are pregnant or have recently given birth, whether they have a qualifying medical condition or whether they are in receipt of certain benefits or a war pension.
People on low incomes can apply for help with their health costs through the NHS Low Income Scheme. People who need to pay and need many prescription items could save money with a prescription prepayment certificate (PPC). PPCs allow people to claim as many prescriptions as they need for a set cost, with 3-month and 12-month certificates available. The 12-month PPC can be paid for in direct debit instalments.
Asked by: Maya Ellis (Labour - Ribble Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to (a) increase the provision of and (b) improve autism services in (i) Ribble Valley constituency and (ii) Lancashire.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
On 5 April 2023, NHS England published a national framework and operational guidance to help integrated care boards (ICBs) and the National Health Service to deliver improved outcomes for children, young people and adults referred to an autism assessment service. The guidance also sets out what support should be available before an assessment and what support should follow a recent diagnosis of autism, based on the available evidence. Since publication, NHS England has been supporting systems and services to identify where there are challenges for implementation and how they might overcome these.
The NHS Lancashire and South Cumbria ICB has secured £1.8 million in funding to improve the Neurodivergent Pathway across Lancashire and South Cumbria, which the ICB has decided will primarily focus on children and young people (CYP) in the first instance, given the complexities and inconsistency of current CYP pathways. This investment will support frontline services, digital systems, a redesign of clinical pathways, and an increase in direct support available for families and young people. The ICB is working closely with Lancashire County Council and local schools to ensure the offer is joined up. The ICB has also commissioned an all-age online pre- and post-diagnostic support resource.
Asked by: Maya Ellis (Labour - Ribble Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with the Care Quality Commission on whether the increase in the level of NHS-funded nursing care has increased the quality of care provided in care homes.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
There have been no discussions between the department and the Care Quality Commission (CQC) on NHS-funded nursing care (FNC).
The department is responsible for FNC policy and for setting the FNC rate each year. NHSE and integrated care boards (ICBs) are responsible for the implementation of FNC, including paying the FNC rate direct to care homes with nursing.
The FNC rate for 2025/26 increased by 7.7% from the 2024/25 rate. From the 1 April 2025, this increases the standard weekly rate per eligible individual from £235.88 to £254.06 and from £324.50 to £349.50 for the higher rate payment. FNC contributes to the provision of nursing care by a registered nurse and does not cover the costs of wider non-nursing care or accommodation. The rate increase accounts for the increase in the cost of providing nursing care.
Providers registered with CQC are expected to comply with the fundamental standards under the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014. CQC monitor and assess services and publish their findings, and can take regulatory and enforcement action if services are not providing people with safe, effective, compassionate, high-quality care.
Asked by: Maya Ellis (Labour - Ribble Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people were recruited into National Institute for Health and Care Research supported phase 3 trials for (a) dementia, (b) cancer, (c) stroke and (d) coronary heart disease in the last five years.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
A table showing the number of participants recruited into phase three trials in England, supported by the National Institute for Health and Care Research, for dementia, cancer, stroke, and coronary heart disease in the last five years is attached. It should be noted that this includes studies on atherothrombosis and the prevention of coronary artery disease.
The numbers of participants declined between the years 2020/21 and 2021/22. While it is not possible to confirm the exact reasons for this decline, this is likely due to the impact of the COVID-19 pandemic, and the focus on recruiting participants to urgent COVID-19 studies over these years. Other fluctuations are likely due to large sample size studies within the dataset, which have since opened or closed recruitment.
Asked by: Maya Ellis (Labour - Ribble Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the availability of beds in psychiatric intensive care units in (a) Lancashire and South Cumbria NHS Foundation Trust and (b) other NHS trusts.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The number of mental health inpatient beds required to support a local population is dependent on both local mental health need and the effectiveness of the whole local mental health system in providing timely access to care and supporting people to stay well in the community, therefore reducing the likelihood of an inpatient admission being necessary.
The Department expects individual trusts and local health systems to effectively assess and manage bed capacity and the ‘flow’ of patients being discharged or moving to another setting.
Over the past few years, the National Health Service has been developing the community mental health framework to improve community support for people with severe mental illness, thus avoiding the need for an inpatient admission where possible, and freeing up more beds.
The 2025/26 NHS Planning Guidance sets out the expectation that ICBs should work with providers to improve patient flow through mental health crisis and acute pathways, reducing the average length of stay in adult acute beds, and improving access to children and young people’s mental health services.
As part of our mission to build an NHS fit for the future, we will make sure more mental health care is delivered in the community, close to people’s homes, through new models of care and support, so that fewer people need to go into hospital.
Asked by: Maya Ellis (Labour - Ribble Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of changes to employer National Insurance contributions on care home providers.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Government did consider the cost pressures facing adult social care as part of the wider consideration of local government spending within the Spending Review process in 2024.
To enable local authorities to deliver key services such as adult social care, the Government has made available up to £3.7 billion of additional funding for social care authorities in 2025/26, which includes an £880 million increase in the Social Care Grant.
Asked by: Maya Ellis (Labour - Ribble Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve pain management treatment for people with chronic urinary tract infections.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guidelines are evidence-based recommendations for health and care in England and Wales. They help health and social care professionals to prevent ill health, promote good health, and improve the quality of care and services. Practitioners are expected to refer to the NICE’s guidance when assessing, signposting to, and prescribing pain relief medications, including for chronic urinary tract infections (UTIs).
When providing clinical care for conditions such as chronic UTIs, it is a prescriber’s duty to prescribe medicines, including for pain relief, when they have adequate knowledge of the patient’s health and are satisfied that the medicine is clinically suitable for the patient.
Asked by: Maya Ellis (Labour - Ribble Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what proportion of eligible families are receiving Healthy Start in Ribble Valley constituency.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The NHS Business Services Authority (NHSBSA) operates the Healthy Start scheme on behalf of the Department. Monthly figures for the number of people on the digital Healthy Start scheme are published on the NHS Healthy Start website, which is available at the following link:
https://www.healthystart.nhs.uk/healthcare-professionals/
The NHSBSA does not hold data on the number of families receiving Healthy Start. The number of people on the scheme in March 2025 for Ribble Valley was 104.
The NHSBSA does not currently hold data on the number of people who are eligible for the scheme. An issue was identified with the source data that is used to calculate uptake of the NHS Healthy Start scheme. The NHSBSA has therefore removed data for the number of people eligible for the scheme and the uptake percentage from January 2023 onwards.
The issue has only affected the data on the number of people eligible for the scheme. It has not prevented anyone from joining the scheme or continuing to access the scheme if they were eligible.